Dietary Interventions in Multiple Sclerosis: Development and Pilot-Testing of an Evidence Based Patient Education Program

被引:36
作者
Riemann-Lorenz, Karin [1 ]
Eilers, Marlene [1 ]
von Geldern, Gloria [2 ]
Schulz, Karl-Heinz [3 ,4 ]
Kopke, Sascha [5 ]
Heesen, Christoph [6 ,7 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Inst Neuroimmunol & Multiple Sclerosis, Hamburg, Germany
[2] Univ Washington, Dept Neurol, Seattle, WA 98195 USA
[3] Univ Med Ctr Hamburg Eppendorf, Dept Psychosocial Med, Inst Med Psychol, Hamburg, Germany
[4] Univ Med Ctr Hamburg Eppendorf, Athleticum Competence Ctr Sports & Exercise Med, Hamburg, Germany
[5] Univ Lubeck, Inst Social Med & Epidemiol, Nursing Res Unit, Lubeck, Germany
[6] MS Day Hosp, Dept Neurol, Hamburg, Germany
[7] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Multiple Sclerosis, Hamburg, Germany
来源
PLOS ONE | 2016年 / 11卷 / 10期
关键词
POLYUNSATURATED FATTY-ACIDS; DOUBLE-BLIND TRIAL; SUPPLEMENTATION; VITAMIN-D-3; DISEASE; RISK;
D O I
10.1371/journal.pone.0165246
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Dietary factors have been discussed to influence risk or disease course of multiple sclerosis (MS). Specific diets are widely used among patients with MS. Objective To design and pilot-test an evidence based patient education program on dietary factors in MS. Methods We performed a systematic literature search on the effectiveness of dietary interventions in MS. A web-based survey among 337 patients with MS and 136 healthy controls assessed knowledge, dietary habits and information needs. An interactive group education program was developed and pilot-tested. Results Fifteen randomised-controlled trials (RCTs) were included in the systematic review. Quality of evidence was low and no clear benefit could be seen. Patients with MS significantly more often adhered to a 'Mediterranean Diet'(29.7% versus 14.0%, p< 0.001) compared to controls. 143 (42%) of the patients with MS had tried special MS diets. Important information needs addressed effectiveness of MS diets (44%) and relation between nutrition and MS (43%). A pilot test of our newly developed patient education program with 13 participants showed excellent comprehensibility and the MS-specific content was judged as very important. However, the poor evidence base for dietary approaches in MS was perceived disappointing. Conclusions Development and pilot-testing of an evidence-based patient education program on nutrition and MS is feasible. Patient satisfaction with the program suffers from the lack of evidence. Further research should focus on generating evidence for the potential influence of lifestyle habits (diet, physical activity) on MS disease course thus meeting the needs of patients with MS.
引用
收藏
页数:20
相关论文
共 45 条
  • [31] Criteria for Reporting the Development and Evaluation of Complex Interventions in healthcare: revised guideline (CReDECI 2)
    Moehler, Ralph
    Koepke, Sascha
    Meyer, Gabriele
    [J]. TRIALS, 2015, 16
  • [32] Moher D, 2015, SYST REV-LONDON, V4, DOI [10.1186/2046-4053-4-1, 10.1136/bmj.i4086, 10.1016/j.ijsu.2010.07.299, 10.1371/journal.pmed.1000097, 10.1136/bmj.b2700, 10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]
  • [33] Screening for depression among patients with multiple sclerosis: two questions may be enough
    Mohr, D. C.
    Hart, S. L.
    Julian, L.
    Tasch, E. S.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2007, 13 (02) : 215 - 219
  • [34] A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial
    Pantzaris, Marios C.
    Loukaides, George N.
    Ntzani, Evangelia E.
    Patrikios, Ioannis S.
    [J]. BMJ OPEN, 2013, 3 (04):
  • [35] DOUBLE-BLIND TRIAL OF LINOLEIC-ACID IN MULTIPLE-SCLEROSIS
    PATY, DW
    [J]. ARCHIVES OF NEUROLOGY, 1983, 40 (11) : 693 - 694
  • [36] Pereira M., 1997, Medicine Science in Sports Exercise, V26, P36, DOI DOI 10.1097/00005768-199706001-00009
  • [37] Complementary and alternative medicine for multiple sclerosis
    Schwarz, S.
    Knorr, C.
    Geiger, H.
    Flachenecker, P.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2008, 14 (08) : 1113 - 1119
  • [38] Effects of Adjunct Low-Dose Vitamin D on Relapsing-Remitting Multiple Sclerosis Progression: Preliminary Findings of a Randomized Placebo-Controlled Trial
    Shaygannejad, Vahid
    Janghorbani, Mohsen
    Ashtari, Fereshteh
    Dehghan, Hamed
    [J]. MULTIPLE SCLEROSIS INTERNATIONAL, 2012, 2012
  • [39] A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis
    Soilu-Hanninen, Merja
    Aivo, Julia
    Lindstrom, Britt-Marie
    Elovaara, Irina
    Sumelahti, Marja-Liisa
    Farkkila, Markus
    Tienari, Pentti
    Atula, Sari
    Sarasoja, Taneli
    Herrala, Lauri
    Keskinarkaus, Irma
    Kruger, Johanna
    Kallio, Timo
    Rocca, Maria A.
    Filippi, Massimo
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 (05) : 566 - 572
  • [40] The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis
    Storoni, Mithu
    Plant, Gordon T.
    [J]. MULTIPLE SCLEROSIS INTERNATIONAL, 2015, 2015